A new vaccine for tuberculosis: The challenges of development and deployment [Book Review]

Journal of Bioethical Inquiry 6 (2):219-228 (2009)
  Copy   BIBTEX

Abstract

Tuberculosis (TB) is one of the world’s leading causes of death due to infection and efforts to control TB would be substantially aided by the availability of an improved TB vaccine. There are currently nine new TB vaccines in clinical development, and the first efficacy trials are due to commence in 2009. There are many complex ethical issues which arise at all stages of TB vaccine development, from the need to conduct trials in developing countries to informed consent and the process of ethical review. While it is important that these issues are discussed, it may also be timely to consider the challenges which may arise if a vaccine in clinical development proves to be highly effective. We examine a number of scenarios where decisions on the deployment of a new TB vaccine may impact on the rights and liberty of the individual.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 89,703

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Industry, innovation and social values.Harvey E. Bale - 2005 - Science and Engineering Ethics 11 (1):31-40.
Hiv preventive vaccine research: Selected ethical issues.Christine Grady - 1994 - Journal of Medicine and Philosophy 19 (6):595-612.

Analytics

Added to PP
2009-05-09

Downloads
30 (#453,813)

6 months
5 (#242,735)

Historical graph of downloads
How can I increase my downloads?